Lexicon Pharma: Inpefa’s Early Clinical Benefits, Rehospitalization Data May Unlock Value
apomares/E+ via Getty Images Introduction & Thesis Shares of biopharma Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are ~60% off their May highs, ...
apomares/E+ via Getty Images Introduction & Thesis Shares of biopharma Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are ~60% off their May highs, ...
Zhanna Hapanovich/iStock via Getty Images Aurinia Pharmaceuticals (NASDAQ:AUPH) soared 6.7% amid takeover speculation. The Aurinia (AUPH) stock surge comes amid ...
Indian market closed in the red for the second day in a row on Monday. The S&P BSE Sensex fell ...
Bayer Cropscience, Cigniti Technologies, Container Corporation of India, MSTC, Power Grid Corporation, Saksoft and Sundaram Fasteners will trade ex-dividend, while ...
Nadzeya Haroshka The top pharmaceutical lobby group, PhRMA, and drug middlemen known as pharmacy benefit managers (PBM) have resumed their ...
Piramal Pharma clocked 11 per cent growth in revenue from operations at Rs 1,911 crore in the second quarter ended ...
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men’s health issues. ...
marekuliasz/iStock via Getty Images Sales of diabetes and weight loss drugs are booming, propelling Eli Lilly (NYSE:LLY) and Novo Nordisk ...
ipopba Deals and Financings Novartis (NVS) signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing ...
Indian market is expected to trade higher on Wednesday tracking positive global cues. The S&P BSE Sensex rose more than ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.